 Edward Chuong
Concepts (172)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Endogenous Retroviruses | 8 | 2024 | 36 | 4.310 |
Why?
| | DNA Transposable Elements | 9 | 2024 | 122 | 3.690 |
Why?
| | Evolution, Molecular | 7 | 2024 | 488 | 1.900 |
Why?
| | Regulatory Sequences, Nucleic Acid | 4 | 2023 | 92 | 1.470 |
Why?
| | Gene Expression Regulation, Neoplastic | 4 | 2024 | 1402 | 1.230 |
Why?
| | Enhancer Elements, Genetic | 6 | 2024 | 190 | 1.140 |
Why?
| | Gene Regulatory Networks | 4 | 2024 | 308 | 1.090 |
Why?
| | Interferon-gamma | 2 | 2023 | 790 | 1.030 |
Why?
| | Placenta | 7 | 2018 | 754 | 0.950 |
Why?
| | Receptor, Interferon alpha-beta | 1 | 2024 | 34 | 0.910 |
Why?
| | Promoter Regions, Genetic | 3 | 2024 | 1255 | 0.880 |
Why?
| | Exons | 1 | 2024 | 349 | 0.840 |
Why?
| | Alternative Splicing | 1 | 2024 | 227 | 0.790 |
Why?
| | Retroelements | 1 | 2022 | 47 | 0.770 |
Why?
| | Gene Expression Regulation | 4 | 2022 | 2615 | 0.770 |
Why?
| | Signal Transduction | 5 | 2024 | 5096 | 0.760 |
Why?
| | Gene Editing | 1 | 2023 | 82 | 0.750 |
Why?
| | CRISPR-Cas Systems | 1 | 2023 | 123 | 0.730 |
Why?
| | Immunity, Innate | 3 | 2024 | 832 | 0.600 |
Why?
| | Corticotropin-Releasing Hormone | 1 | 2018 | 67 | 0.580 |
Why?
| | Animals | 27 | 2025 | 37011 | 0.550 |
Why?
| | Colorectal Neoplasms | 1 | 2024 | 799 | 0.520 |
Why?
| | Histone-Lysine N-Methyltransferase | 3 | 2024 | 141 | 0.480 |
Why?
| | Dosage Compensation, Genetic | 1 | 2013 | 9 | 0.430 |
Why?
| | Mammals | 3 | 2023 | 286 | 0.430 |
Why?
| | X Chromosome | 1 | 2013 | 53 | 0.430 |
Why?
| | Ruminants | 2 | 2024 | 7 | 0.430 |
Why?
| | Ovarian Neoplasms | 3 | 2024 | 563 | 0.420 |
Why?
| | Protein Isoforms | 2 | 2024 | 403 | 0.400 |
Why?
| | Drosophila | 1 | 2013 | 146 | 0.390 |
Why?
| | Cell Line, Tumor | 6 | 2024 | 3420 | 0.380 |
Why?
| | Drosophila Proteins | 1 | 2013 | 202 | 0.370 |
Why?
| | T-Lymphocytes | 1 | 2020 | 1999 | 0.360 |
Why?
| | Pregnancy Proteins | 2 | 2011 | 36 | 0.350 |
Why?
| | Epigenesis, Genetic | 4 | 2024 | 660 | 0.320 |
Why?
| | Stem Cells | 2 | 2013 | 589 | 0.310 |
Why?
| | Maternal-Fetal Exchange | 1 | 2010 | 165 | 0.300 |
Why?
| | Poly(ADP-ribose) Polymerase Inhibitors | 3 | 2024 | 117 | 0.290 |
Why?
| | Chromatin | 3 | 2024 | 524 | 0.270 |
Why?
| | Placentation | 3 | 2017 | 45 | 0.260 |
Why?
| | Transcription Factors | 2 | 2016 | 1717 | 0.260 |
Why?
| | Genome | 4 | 2024 | 292 | 0.240 |
Why?
| | HEK293 Cells | 2 | 2025 | 734 | 0.240 |
Why?
| | Interferon-beta | 1 | 2025 | 92 | 0.230 |
Why?
| | Proto-Oncogene Protein c-ets-1 | 1 | 2024 | 25 | 0.230 |
Why?
| | Drug Resistance, Neoplasm | 3 | 2024 | 806 | 0.230 |
Why?
| | RNA Stability | 1 | 2025 | 117 | 0.220 |
Why?
| | Transcription, Genetic | 3 | 2024 | 1458 | 0.220 |
Why?
| | Rhabdomyosarcoma | 1 | 2024 | 72 | 0.210 |
Why?
| | Pregnancy | 7 | 2018 | 6745 | 0.210 |
Why?
| | Interferons | 1 | 2024 | 199 | 0.210 |
Why?
| | Humans | 21 | 2025 | 137514 | 0.200 |
Why?
| | Oncogene Proteins, Fusion | 1 | 2024 | 215 | 0.200 |
Why?
| | Carcinogenesis | 1 | 2024 | 220 | 0.200 |
Why?
| | Gene Knockout Techniques | 1 | 2023 | 116 | 0.190 |
Why?
| | Gene Expression Regulation, Developmental | 5 | 2017 | 856 | 0.190 |
Why?
| | Binding Sites | 2 | 2023 | 1310 | 0.190 |
Why?
| | Mice | 9 | 2025 | 17843 | 0.190 |
Why?
| | Gene Targeting | 1 | 2021 | 83 | 0.180 |
Why?
| | Biological Evolution | 2 | 2023 | 466 | 0.180 |
Why?
| | Telomere | 1 | 2024 | 280 | 0.180 |
Why?
| | Research Report | 1 | 2021 | 83 | 0.180 |
Why?
| | RNA, Untranslated | 1 | 2021 | 124 | 0.170 |
Why?
| | Congresses as Topic | 1 | 2021 | 233 | 0.170 |
Why?
| | Cattle | 1 | 2022 | 982 | 0.160 |
Why?
| | Nuclear Proteins | 1 | 2024 | 710 | 0.160 |
Why?
| | Haplorhini | 1 | 2018 | 53 | 0.150 |
Why?
| | Cell Line | 2 | 2023 | 2852 | 0.150 |
Why?
| | RNA, Long Noncoding | 2 | 2021 | 181 | 0.150 |
Why?
| | CD8-Positive T-Lymphocytes | 1 | 2024 | 917 | 0.150 |
Why?
| | Eutheria | 1 | 2017 | 3 | 0.140 |
Why?
| | Primates | 1 | 2018 | 125 | 0.140 |
Why?
| | Selection, Genetic | 3 | 2024 | 262 | 0.140 |
Why?
| | Endonucleases | 1 | 2016 | 32 | 0.130 |
Why?
| | Xenopus | 2 | 2013 | 87 | 0.130 |
Why?
| | Lactation | 1 | 2017 | 184 | 0.130 |
Why?
| | Chromatin Immunoprecipitation | 2 | 2013 | 139 | 0.130 |
Why?
| | RNA, Fungal | 1 | 2016 | 72 | 0.130 |
Why?
| | Gene Expression Regulation, Fungal | 1 | 2016 | 73 | 0.120 |
Why?
| | Genome, Human | 2 | 2016 | 424 | 0.120 |
Why?
| | Endoderm | 2 | 2011 | 19 | 0.110 |
Why?
| | Inflammasomes | 1 | 2016 | 128 | 0.110 |
Why?
| | Trophoblasts | 2 | 2013 | 198 | 0.110 |
Why?
| | Rats | 3 | 2013 | 5676 | 0.110 |
Why?
| | Forkhead Transcription Factors | 2 | 2011 | 191 | 0.110 |
Why?
| | Terminal Repeat Sequences | 1 | 2013 | 17 | 0.110 |
Why?
| | Embryonic Stem Cells | 2 | 2011 | 123 | 0.110 |
Why?
| | Phylogeny | 2 | 2024 | 898 | 0.100 |
Why?
| | Genomics | 1 | 2018 | 793 | 0.100 |
Why?
| | DNA Copy Number Variations | 1 | 2014 | 185 | 0.100 |
Why?
| | Female | 10 | 2024 | 73162 | 0.100 |
Why?
| | High-Throughput Nucleotide Sequencing | 2 | 2013 | 538 | 0.100 |
Why?
| | Acetylation | 1 | 2013 | 254 | 0.100 |
Why?
| | Smad Proteins, Receptor-Regulated | 1 | 2011 | 2 | 0.090 |
Why?
| | Saccharomyces cerevisiae | 1 | 2016 | 562 | 0.090 |
Why?
| | Nodal Protein | 1 | 2011 | 3 | 0.090 |
Why?
| | Species Specificity | 1 | 2013 | 593 | 0.090 |
Why?
| | Antineoplastic Agents | 1 | 2023 | 2145 | 0.090 |
Why?
| | Histones | 2 | 2013 | 641 | 0.080 |
Why?
| | Cathepsins | 1 | 2010 | 24 | 0.080 |
Why?
| | Prolactin | 1 | 2010 | 100 | 0.080 |
Why?
| | Basic Helix-Loop-Helix Transcription Factors | 1 | 2011 | 242 | 0.080 |
Why?
| | Neoplasms | 1 | 2024 | 2666 | 0.080 |
Why?
| | Jumonji Domain-Containing Histone Demethylases | 2 | 2024 | 68 | 0.080 |
Why?
| | Amino Acid Sequence | 2 | 2010 | 2146 | 0.070 |
Why?
| | Spermatogenesis | 1 | 2008 | 67 | 0.070 |
Why?
| | DNA-Binding Proteins | 1 | 2016 | 1507 | 0.070 |
Why?
| | Rodentia | 1 | 2008 | 57 | 0.070 |
Why?
| | Molecular Sequence Data | 2 | 2010 | 2901 | 0.070 |
Why?
| | Testis | 1 | 2008 | 150 | 0.070 |
Why?
| | Analysis of Variance | 1 | 2010 | 1324 | 0.070 |
Why?
| | Health Status | 1 | 2011 | 784 | 0.060 |
Why?
| | Adaptation, Physiological | 1 | 2010 | 546 | 0.060 |
Why?
| | Tristetraprolin | 1 | 2025 | 8 | 0.060 |
Why?
| | Gammaherpesvirinae | 1 | 2025 | 47 | 0.060 |
Why?
| | PAX3 Transcription Factor | 1 | 2024 | 17 | 0.060 |
Why?
| | Paired Box Transcription Factors | 1 | 2024 | 46 | 0.060 |
Why?
| | Diploidy | 1 | 2024 | 18 | 0.060 |
Why?
| | Histocompatibility Antigens | 1 | 2024 | 107 | 0.050 |
Why?
| | Gene Expression Profiling | 1 | 2011 | 1770 | 0.050 |
Why?
| | Activating Transcription Factor 6 | 1 | 2023 | 18 | 0.050 |
Why?
| | Protein Binding | 3 | 2016 | 2229 | 0.050 |
Why?
| | Transcription Factor AP-1 | 1 | 2023 | 92 | 0.050 |
Why?
| | Virus Replication | 1 | 2025 | 480 | 0.050 |
Why?
| | Snake Venoms | 1 | 2022 | 25 | 0.050 |
Why?
| | Crotalus | 1 | 2022 | 26 | 0.050 |
Why?
| | Proteins | 1 | 2008 | 1012 | 0.050 |
Why?
| | Mutation | 1 | 2013 | 3964 | 0.050 |
Why?
| | RNA, Small Untranslated | 1 | 2021 | 16 | 0.050 |
Why?
| | RNA-Binding Proteins | 1 | 2025 | 424 | 0.040 |
Why?
| | Xenograft Model Antitumor Assays | 1 | 2024 | 868 | 0.040 |
Why?
| | MicroRNAs | 2 | 2021 | 704 | 0.040 |
Why?
| | RNA, Small Interfering | 1 | 2021 | 621 | 0.040 |
Why?
| | Drug Delivery Systems | 1 | 2021 | 363 | 0.040 |
Why?
| | RNA, Messenger | 1 | 2025 | 2838 | 0.030 |
Why?
| | Gene Expression | 1 | 2022 | 1505 | 0.030 |
Why?
| | Milk | 1 | 2017 | 123 | 0.030 |
Why?
| | G1 Phase Cell Cycle Checkpoints | 1 | 2016 | 10 | 0.030 |
Why?
| | Mammary Glands, Animal | 1 | 2017 | 129 | 0.030 |
Why?
| | Cell Proliferation | 1 | 2024 | 2482 | 0.030 |
Why?
| | Mediator Complex | 1 | 2016 | 61 | 0.030 |
Why?
| | Polymorphism, Genetic | 1 | 2018 | 658 | 0.030 |
Why?
| | Cell Differentiation | 2 | 2014 | 1979 | 0.030 |
Why?
| | Nucleosomes | 1 | 2016 | 156 | 0.030 |
Why?
| | Polyploidy | 1 | 2014 | 19 | 0.030 |
Why?
| | Stochastic Processes | 1 | 2014 | 71 | 0.030 |
Why?
| | Disease Models, Animal | 1 | 2024 | 4295 | 0.030 |
Why?
| | Chromatin Assembly and Disassembly | 1 | 2013 | 106 | 0.020 |
Why?
| | Base Sequence | 1 | 2016 | 2180 | 0.020 |
Why?
| | Cell Adhesion | 1 | 2014 | 467 | 0.020 |
Why?
| | Gene Deletion | 1 | 2014 | 393 | 0.020 |
Why?
| | Saccharomyces cerevisiae Proteins | 1 | 2016 | 404 | 0.020 |
Why?
| | Neurogenesis | 1 | 2014 | 149 | 0.020 |
Why?
| | Physiology, Comparative | 1 | 2011 | 3 | 0.020 |
Why?
| | Fetal Proteins | 1 | 2011 | 17 | 0.020 |
Why?
| | Left-Right Determination Factors | 1 | 2011 | 1 | 0.020 |
Why?
| | Gastrulation | 1 | 2011 | 9 | 0.020 |
Why?
| | Smad Proteins | 1 | 2011 | 42 | 0.020 |
Why?
| | Male | 3 | 2013 | 67718 | 0.020 |
Why?
| | Amino Acid Motifs | 1 | 2011 | 225 | 0.020 |
Why?
| | Immunomodulation | 1 | 2011 | 98 | 0.020 |
Why?
| | Methylation | 1 | 2011 | 237 | 0.020 |
Why?
| | Organ Specificity | 1 | 2011 | 304 | 0.020 |
Why?
| | Stem Cell Transplantation | 1 | 2011 | 177 | 0.020 |
Why?
| | Oligonucleotide Array Sequence Analysis | 1 | 2011 | 765 | 0.020 |
Why?
| | Lysine | 1 | 2011 | 297 | 0.020 |
Why?
| | Peromyscus | 1 | 2008 | 7 | 0.020 |
Why?
| | Expressed Sequence Tags | 1 | 2008 | 42 | 0.020 |
Why?
| | Sequence Alignment | 1 | 2008 | 345 | 0.020 |
Why?
| | Biomedical Research | 1 | 2011 | 689 | 0.010 |
Why?
| | Reproducibility of Results | 1 | 2011 | 3292 | 0.010 |
Why?
| | Time Factors | 1 | 2011 | 6817 | 0.010 |
Why?
|
|
Chuong's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors People in Profiles who have published with this person. _
Similar People People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
Physical Neighbors People whose addresses are nearby this person. _
|